Resources to Advance Pediatrics and HIV Prevention Science: Scientific and Quality/Regulatory Support Services
- Institution
- ADVANCED BIOSCIENCE LABORATORIES, INC., MD
- Principal investigator
- Peter Silvera
- Funding
- $66K
- Duration
- 2025–2026
Moonbase score
Still being scored
Abstract
The objective of the Resource to Advance Pediatrics and HIV Prevention Science contracts is to provide the extramural scientific community with research materials and preclinical product development support for candidate products that emerge from investigator-initiated research studies, or from collaborations with private sector or academic partners. These services may also be used to support product discovery and development leading to IND, Investigational Device Exemption (IDE), and/or New Drug Application (NDA) filings with the FDA. NIAID will primarily use these contracts to fill critical development and resource gaps more rapidly and efficiently and advance promising products into clinical testing. The focus of these contracts will be development of therapeutics and prevention products for HIV, including single or combination products with activity against associated co-infections or MPTs that incorporate contraceptives.
LOADING MOONBASE SCORE
Questions for ADVANCED BIOSCIENCE LABORATORIES, INC.
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Advanced Bioscience Laboratories, Inc.Not yet scored
Resource to Advance Pediatrics and HIV Prevention Science (RAPPS): Quality Assurance/Quality Control (QA/QC) Support
Peter Silvera · $551K · 2025–2026
- NIH · Advanced Bioscience Laboratories, Inc.Not yet scored
Next Generation Development of Broadly Neutralizing HIV Antibodies for Prevention
Timothy Fouts · $181K · 2025–2028
- NIH · Advanced Bioscience Laboratories, Inc.Not yet scored
NIAID Preclinical Development Support - Production of a HIV gp145 Clade C Trimer Protein
Timothy Fouts · $25K · 2025